BamSEC and AlphaSense Join Forces
Learn More

Angiodynamics Inc – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ANGO    
Share price (11/13/26): $11.87    
Market cap (11/13/26): $499 million

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 49 pages Asset Purchase Agreement by and Between Merit Medical Systems, Inc. and Angiodynamics, Inc. Dated as of June 8, 2023
12/34/56
EX-2.1
from 8-K 83 pages Asset Purchase Agreement Dated as of April 17, 2019 by and Between Angiodynamics, Inc. and Medline Industries, Inc
12/34/56
EX-2.1
from 8-K 87 pages Stock Purchase Agreement Dated as of October 8, 2012 by and Among Angiodynamics, Inc., and Vortex Medical, Inc. Catalyst Health Ventures (P.F.) L.P., Chtp/Funding, LLC, Catalyst Health Ventures L.P., James Ward, Pavilion Holdings Group, L.L.C., Michael J. Glennon, Brian Deguzman, Lishan Aklog, Albert Chin, and the Optionholders Named Herein and Chtp Management Services, Inc., as Sellers’ Representative
12/34/56
EX-2.2
from 8-K 44 pages Stockholders Agreement Dated as of May 22, 2012 by and Among Angiodynamics, Inc. and the Stockholders Named Herein
12/34/56
EX-2.2
from 8-K 44 pages Stockholders Agreement Dated as of [●], 2012 Among Angiodynamics, Inc. and the Stockholders Named Herein
12/34/56
EX-2.2
from DEFA14A 44 pages Stockholders Agreement Dated as of [●], 2012 Among Angiodynamics, Inc. and the Stockholders Named Herein
12/34/56
EX-2.1
from 8-K 101 pages Stock Purchase Agreement Dated as of January 30, 2012 Among Angiodynamics, Inc., Nm Holding Company, Inc., the Stockholders Named Herein, Solely With Respect To, and as Specified In, Sections 2.4 and 7.11(b) the Optionholders Who Execute Joinder Agreements, and Solely With Respect To, and as Specified In, Section 2.6 and Article XII Avista Capital Partners GP, LLC, in Its Capacity as the Sellers’ Representative
12/34/56
EX-2.1
from DEFA14A 101 pages Stock Purchase Agreement Dated as of January 30, 2012 Among Angiodynamics, Inc., Nm Holding Company, Inc., the Stockholders Named Herein, Solely With Respect To, and as Specified In, Sections 2.4 and 7.11(b) the Optionholders Who Execute Joinder Agreements, and Solely With Respect To, and as Specified In, Section 2.6 and Article XII Avista Capital Partners GP, LLC, in Its Capacity as the Sellers’ Representative
12/34/56
EX-2.7
from 10-K 24 pages Dated 10 April 2008 Diomed Limited (In Administration) (1) Steven Law (As Administrator) (2) Angiodynamics Inc. (3) Sale of the Business and Assets of Diomed Limited (In Administration) Taylor Vinters Merlin Place Milton Road Cambridge Cb4 0dp Tel: 01223 423444 Fax: 01223 423944 Email: Username@taylorvinters.com Our Ref: Abb Docnumber Sale of the Business and Assets of Diomed Limited (In Administration) Index
12/34/56
EX-2.6
from 10-K 35 pages Asset Purchase Agreement
12/34/56
EX-2
from 8-K ~5 pages Amendment No. 2 to the Agreement and Plan of Merger
12/34/56
EX-2.1
from 10-Q 40 pages Stock Purchase Agreement
12/34/56
EX-2
from 425 >50 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2
from 8-K >50 pages Plan of reorganization, merger, acquisition or similar
12/34/56